Contact this trialFirst, we need to learn more about you.
WNT/β-catenin signaling pathway inhibitor
ST316 for Advanced Cancers
Recruiting1 awardPhase 1
Durham, North Carolina
This trial tests a new cancer drug to find if it's safe, how it works, and if it's effective against advanced solid tumors.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.